Stage IIIB Breast Cancer Completed Phase 2 Trials for Trimetrexate (DB01157)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003199Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerTreatment
NCT00119262Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerTreatment